Development of a new accurate lateral flow immunoassay for diagnosis of human leptospirosis
European Journal of Clinical Microbiology & Infectious Diseases · 2024
DOI: 10.1007/s10096-024-04912-w ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Microbiology & Infectious Diseases, 2024. Verfasst von Nazarena Pujato und 8 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Bioquímica y Ciencias Biológicas (FBCB), Universidad Nacional del Litoral (UNL), Ruta Nacional Nº 168, km 472., Santa Fe (CP 3000), Argen…. Hauptthemen laut MEDLINE: Leptospirosis, Sensitivity and Specificity, Antibodies, Bacterial, Enzyme-Linked Immunosorbent Assay. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Administración Nacional de Laboratorios e Institutos de Salud (ANLIS) "Carlos G. Malbrán", Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación (ANPyCT), Administración Nacional de Laboratorios e Institutos de Salud (ANLIS) “Carlos G. Malbrán”.
Abstract (Originalsprache)
PURPOSE: The current diagnostic methods for leptospirosis diagnosis are technically complex and expensive, with limited applicability to specialized laboratories. Furthermore, they lack diagnostic accuracy in the acute stage of the disease, which coincides with a period when antibiotics are highly effective. New simple and accurate tests are mandatory to decentralize and improve diagnosis. Here, we introduced a new lateral flow immunoassay (Lepto-LF) for human leptospirosis. METHODS: We conducted a double-blinded assay using 104 serum samples from patients with confirmed or discarded diagnosis for leptospirosis. The diagnostic performance of Lepto-LF was estimated across different ranges of days from onset of symptoms (dpo), considering the diagnostic algorithm as reference standard. Additionally, it was compared with the screening methods enzyme-linked immunosorbent assay (IgM-ELISA) and the slide agglutination test using temperature-resistant antigen (SATR). RESULTS: Lepto-LF exhibited perfect diagnostic performance with a Youden´s index J = 1 from 6 dpo in the acute phase. IgM-ELISA gave slightly lower accuracy with J = 0.91 and 95.5% of both sensitivity and specificity; while SATR showed a markedly inferior yield (J = 0.41, sensitivity = 95.5%, specificity = 45.5%). The performances remained consistent in the convalescence phase of the disease (> 10 dpo). CONCLUSION: Lepto-LF was found to be a reliable test for simple, rapid and early diagnosis of leptospirosis, resulting a promising tool for decentralizing leptospirosis diagnosis and enabling timely treatment of patients. In addition, Lepto-LF may be employed as confirmatory test, especially in remote areas and vulnerable contexts where the standard MAT is not available.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Facultad de Bioquímica y Ciencias Biológicas (FBCB), Universidad Nacional del Litoral (UNL), Ruta Nacional Nº 168, km 472., Santa Fe (CP 3000), Argentina. nazarenapujato@gmail.com.
- Instituto Nacional de Enfermedades Respiratorias (INER) "Dr. E. Coni", Administración Nacional de Laboratorios e Institutos de Salud (ANLIS) "Dr. Carlos G. Malbrán", Santa Fe (CP 3000), Argentina. nazarenapujato@gmail.c…
- Facultad de Bioquímica y Ciencias Biológicas (FBCB), Universidad Nacional del Litoral (UNL), Ruta Nacional Nº 168, km 472., Santa Fe (CP 3000), Argentina.
- Instituto de Desarrollo Tecnológico para la Industria Química (INTEC, UNL-CONICET), Santa Fe (CP 3000), Argentina.
- Facultad de Ciencias Médicas (FCM), Universidad Nacional del Litoral (UNL), Santa Fe (CP 3000), Argentina.
- Instituto Nacional de Enfermedades Respiratorias (INER) "Dr. E. Coni", Administración Nacional de Laboratorios e Institutos de Salud (ANLIS) "Dr. Carlos G. Malbrán", Santa Fe (CP 3000), Argentina.
Förderung
- Administración Nacional de Laboratorios e Institutos de Salud (ANLIS) "Carlos G. Malbrán"
- Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación (ANPyCT)
- Administración Nacional de Laboratorios e Institutos de Salud (ANLIS) “Carlos G. Malbrán”
Zitieren
APA
Pujato, N., Gimenez, J. M., Peretti, L. E., Landolt, N. Y., Jacob, P., Chiani, Y. T., Schmeling, M. F., Miraballes, I., & Vanasco, N. B. (2024). Development of a new accurate lateral flow immunoassay for diagnosis of human leptospirosis. European Journal of Clinical Microbiology & Infectious Diseases. https://doi.org/10.1007/s10096-024-04912-w
Vancouver
Pujato N, Gimenez JM, Peretti LE, Landolt NY, Jacob P, Chiani YT, et al. Development of a new accurate lateral flow immunoassay for diagnosis of human leptospirosis. European Journal of Clinical Microbiology & Infectious Diseases. 2024. doi:10.1007/s10096-024-04912-w
BibTeX
@article{Pujato2024,
author = {Pujato, Nazarena and Gimenez, Juan M and Peretti, Leandro E and Landolt, Noelia Y and Jacob, Paulina and Chiani, Yosena T and Schmeling, Maria F and Miraballes, Iris and Vanasco, Norma B},
title = {Development of a new accurate lateral flow immunoassay for diagnosis of human leptospirosis},
journal = {European Journal of Clinical Microbiology & Infectious Diseases},
year = {2024},
doi = {10.1007/s10096-024-04912-w}
}
EUVIMED